4//SEC Filing
Weber David M 4
Accession 0001179110-21-004899
CIK 0000815094other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:28 PM ET
Size
40.2 KB
Accession
0001179110-21-004899
Insider Transaction Report
Form 4
ABIOMED INCABMD
Weber David M
Chief Operating Officer
Transactions
- Sale
Common Stock, $.01 par value
2021-05-03$306.27/sh−1,103$337,816→ 136,829 total - Sale
Common Stock, $.01 par value
2021-05-03$308.16/sh−2,156$664,393→ 131,205 total - Sale
Common Stock, $.01 par value
2021-05-03$309.37/sh−1,610$498,086→ 129,595 total - Sale
Common Stock, $.01 par value
2021-05-03$309.96/sh−2,344$726,546→ 127,251 total - Sale
Common Stock, $.01 par value
2021-05-03$314.05/sh−300$94,215→ 125,617 total - Sale
Common Stock, $.01 par value
2021-05-03$316.00/sh−12$3,792→ 125,232 total - Disposition to Issuer
Stock Option (Right to Buy)
2021-05-03−13,000→ 0 totalExercise: $23.15From: 2014-05-14Exp: 2023-05-14→ Common Stock (13,000 underlying) - Sale
Common Stock, $.01 par value
2021-05-30$317.88/sh−300$95,364→ 124,932 total - Sale
Common Stock, $.01 par value
2021-05-03$315.33/sh−373$117,618→ 125,244 total - Exercise/Conversion
Common Stock, $.01 par value
2021-05-03$23.15/sh+13,000$300,950→ 137,932 total - Sale
Common Stock, $.01 par value
2021-05-03$307.06/sh−3,468$1,064,884→ 133,361 total - Sale
Common Stock, $.01 par value
2021-05-03$311.10/sh−234$72,797→ 127,017 total - Sale
Common Stock, $.01 par value
2021-05-03$312.84/sh−1,100$344,124→ 125,917 total
Holdings
- 15,497(indirect: By Trust)
Common Stock, $.01 par value
- 10,825
Stock Option (Right to Buy)
Exercise: $21.55From: 2015-05-14Exp: 2024-05-14→ Common Stock (0 underlying) - 10,000
Stock Option (right to buy)
Exercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (0 underlying) - 7,000
Stock Option (right to buy)
Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying) - 8,000
Stock Option (right to buy)
Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying) - 6,500
Stock Option (right to buy)
Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (0 underlying) - 6,000
Stock Option (Right to Buy)
Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying) - 5,000
Stock Option (Right to Buy)
Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying)
Footnotes (18)
- [F1]This option becomes exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- [F10]This price represents the sale price of the transactions on the reported date at $308.1575. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F11]This price represents the sale price of the transactions on the reported date at $309.3678. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F12]This price represents the sale price of the transactions on the reported date at $309.9639. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F13]This price represents the sale price of the transactions on the reported date at $311.0984. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F14]This price represents the sale price of the transactions on the reported date at $312.8436. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F15]This price represents the sale price of the transactions on the reported date at $314.0500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F16]This price represents the sale price of the transactions on the reported date at $315.3342. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F17]This price represents the sale price of the transactions on the reported date at $316.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F18]This price represents the sale price of the transactions on the reported date at $317.8800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F2]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- [F3]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- [F4]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F5]Exercise of stock options pursuant to reporting owners 10b5-1 plan.
- [F6]Exercise of stock options pursuant to reporting owners 10b5-1 plan.
- [F7]Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- [F8]This price represents the sale price of the transactions on the reported date at $306.2659. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F9]This price represents the sale price of the transactions on the reported date at $307.0583. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeother
Related Parties
1- filerCIK 0001399519
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:28 PM ET
- Size
- 40.2 KB